{"dataset":"drug-approvals","sample":[{"id":"FDA-ANDA203421-ORIG-1","country":"US","authority":"US Food and Drug Administration (FDA)","application_number":"ANDA203421","application_type":"ANDA","submission":"ORIG-1","product":"PROPOFOL","active_substance":"PROPOFOL","form":"INJECTABLE;INJECTION","holder":"BAXTER HLTHCARE CORP","approval_type":"generic","approval_status":"approved","approval_date":"2026-11-03","approval_year":2026,"submission_class":null,"review_priority":null,"orphan":false,"conditional":null,"accelerated":false,"action_types":[],"reason":null,"reference_product":null,"therapeutic_area":null,"atc_code":null,"legal_status":null,"territory":null,"letter_url":null,"url":"https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203421","language":"en","verification":"official-publication","paid_placement":false,"source_id":"fda-drugsatfda","source_url":"https://www.fda.gov/media/89850/download","retrieved_at":"2026-11-07T01:26:18.826188+00:00"},{"id":"HC-NOC-38589","country":"CA","authority":"Health Canada","application_number":"38589","application_type":"ANDS","submission":null,"product":"JAMP DOXYCYCLINE MR","active_substance":"DOXYCYCLINE MONOHYDRATE","form":null,"holder":"JAMP PHARMA CORPORATION","approval_type":"generic","approval_status":"approved","approval_date":"2026-11-05","approval_year":2026,"submission_class":"Other","review_priority":null,"orphan":null,"conditional":false,"accelerated":null,"action_types":[],"reason":null,"reference_product":"APPRILON (GALDERMA CANADA INC.)","therapeutic_area":null,"atc_code":null,"legal_status":null,"territory":null,"letter_url":null,"url":"https://health-products.canada.ca/noc-ac/info.do?lang=en&no=38589","language":"en","verification":"official-publication","paid_placement":false,"source_id":"health-canada-noc","source_url":"https://health-products.canada.ca/api/notice-of-compliance/noticeofcompliancemain/?lang=en&type=json","retrieved_at":"2026-11-07T01:26:39.386268+00:00"},{"id":"MHRA-PL21597-0120-2026-10-14","country":"GB","authority":"Medicines and Healthcare products Regulatory Agency (MHRA)","application_number":"PL 21597/0120","application_type":null,"submission":null,"product":"BRIVARACETAM G.L. PHARMA 10 MG FILM-COATED TABLETS","active_substance":"BRIVARACETAM","form":null,"holder":"G L PHARMA GMBH","approval_type":"national","approval_status":"approved","approval_date":"2026-10-14","approval_year":2026,"submission_class":null,"review_priority":null,"orphan":null,"conditional":null,"accelerated":null,"action_types":[],"reason":null,"reference_product":null,"therapeutic_area":null,"atc_code":null,"legal_status":"POM","territory":"UK","letter_url":null,"url":"https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026","language":"en","verification":"official-publication","paid_placement":false,"source_id":"mhra-marketing-authorisations","source_url":"https://assets.publishing.service.gov.uk/media/6ad71f08a89985bb9702692d/Marketing_authorisations_granted_1_October_to_14_October_2026.pdf","retrieved_at":"2026-11-07T01:11:28.863323+00:00"},{"id":"HC-NOC-38590","country":"CA","authority":"Health Canada","application_number":"38590","application_type":"SANDS","submission":null,"product":"HYDROMORPHONE HYDROCHLORIDE INJECTION USP","active_substance":"HYDROMORPHONE HCL","form":null,"holder":"STERINOVA INC","approval_type":"supplemental","approval_status":"approved","approval_date":"2026-11-05","approval_year":2026,"submission_class":"Other","review_priority":null,"orphan":null,"conditional":false,"accelerated":null,"action_types":[],"reason":"Update to package labels","reference_product":"HYDROMORPHONE HYDROCHLORIDE INJECTION USP (PFIZER CANADA ULC)","therapeutic_area":null,"atc_code":null,"legal_status":null,"territory":null,"letter_url":null,"url":"https://health-products.canada.ca/noc-ac/info.do?lang=en&no=38590","language":"en","verification":"official-publication","paid_placement":false,"source_id":"health-canada-noc","source_url":"https://health-products.canada.ca/api/notice-of-compliance/noticeofcompliancemain/?lang=en&type=json","retrieved_at":"2026-11-07T01:26:39.386268+00:00"},{"id":"HC-NOC-38577","country":"CA","authority":"Health Canada","application_number":"38577","application_type":"NDS","submission":null,"product":"MFLUSIVA","active_substance":"INFLUENZA A/H1N1 MRNA, 5'(M7G-5'-PPP-5'-GM) CAP, 3' POLY(A) TAIL; INFLUENZA A/H3N2 MRNA, 5'(M7G-5'-PPP-5'-GM) CAP, 3' POLY(A) TAIL; NFLUENZA B/VICTORIA MRNA, 5'(M7G-5'-PPP-5'-GM) CAP, 3' POLY(A) TAIL","form":null,"holder":"MODERNA BIOPHARMA CANADA CORPORATION","approval_type":"new_active_substance","approval_status":"approved","approval_date":"2026-11-04","approval_year":2026,"submission_class":"New Active Substance","review_priority":null,"orphan":null,"conditional":false,"accelerated":null,"action_types":[],"reason":null,"reference_product":null,"therapeutic_area":null,"atc_code":null,"legal_status":null,"territory":null,"letter_url":null,"url":"https://health-products.canada.ca/noc-ac/info.do?lang=en&no=38577","language":"en","verification":"official-publication","paid_placement":false,"source_id":"health-canada-noc","source_url":"https://health-products.canada.ca/api/notice-of-compliance/noticeofcompliancemain/?lang=en&type=json","retrieved_at":"2026-11-07T01:26:39.386268+00:00"}],"feedback":{"message":"Not buying? Tell us why in one free call: we use this feedback to provide a better offering. Do not include personal data.","method":"POST","endpoint":"https://agentdatafeed.com/v1/feedback","mcp_tool":"send_feedback","body":{"type":"no_purchase","dataset":"drug-approvals","reason":"no_budget | cost_too_high | dataset_usability_uncertain | other","comment":"optional free text, max 500 characters (required when reason is other)"}}}